Safety and Immunogenicity of a Rederived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults Living in Thailand: A Randomized Trial

Safety and immunogenicity of two formulations of a live-attenuated tetravalent dengue virus (TDEN) vaccine produced using rederived master seeds from a precursor vaccine were tested against a placebo control in a phase II, randomized, double blind trial (NCT00370682). Two doses were administered 6 m...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Watanaveeradej, Veerachai, Gibbons, Robert V., Simasathien, Sriluck, Nisalak, Ananda, Jarman, Richard G., Kerdpanich, Angkool, Tournay, Elodie, De La Barrerra, Rafael, Dessy, Francis, Toussaint, Jean-François, Eckels, Kenneth H., Thomas, Stephen J., Innis, Bruce L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The American Society of Tropical Medicine and Hygiene 2014
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080550/
https://ncbi.nlm.nih.gov/pubmed/24865677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.13-0452
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia